Schreiber Taylor
SEC CIK 1601942 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| STTK | Shattuck Labs, Inc. | CEO, Dir | 122.2K | $94.1K | — | 8 | 2021-08-10 | 2026-05-12 |
Most active insiders at STTK, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Pandite Arundathy N. | Chief Medical Off | — | $408.6K |
| 2 | SIEGALL CLAY B | Dir | $250.0K | — |
| 3 | Shukla Abhinav A. | Chief Technical Off | — | $183.2K |
| 4 | Stout Stephen | See Remarks | — | — |
| 5 | Neill Andrew R | CFO | — | — |
| 6 | DeYoung Casi | Chief Business Off | — | — |
| 7 | Schreiber Taylor | CEO, Dir | — | — |
Transactions 8
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-05-13 06:05 | 2026-05-12 | STTK | Shattuck Labs, Inc. | Schreiber Taylor | CEO, Dir | A - Grant | $1.08 | +25.6K | 122.2K | +27% | +$27.8K |
| D | 2025-08-27 | 2025-08-25 | STTK | Shattuck Labs, Inc. | Schreiber Taylor | CEO, Dir | A - Grant | $0.87 | +25.6K | 96.6K | +36% | +$22.3K |
| 2024-10-08 | 2024-10-07 | STTK | Shattuck Labs, Inc. | Schreiber Taylor | CEO, Dir | P - Purchase | $1.21 | +36.5K | 71.0K | +106% | +$44.2K | |
| 2024-06-26 | 2024-06-26 | STTK | Shattuck Labs, Inc. | Schreiber Taylor | CEO, Dir | P - Purchase | $3.47 | +14.4K | 34.5K | +72% | +$50.0K | |
| D | 2024-06-05 | 2024-06-04 | STTK | Shattuck Labs, Inc. | Schreiber Taylor | CEO, Dir | M - OptEx | $3.57 | +3,050 | 20.1K | +18% | +$10.9K |
| D | 2022-01-31 | 2022-01-28 | STTK | Shattuck Labs, Inc. | Schreiber Taylor | CEO, Dir | M - OptEx | $4.67 | +3,926 | 17.1K | +30% | +$18.3K |
| D | 2021-11-12 | 2021-11-10 | STTK | Shattuck Labs, Inc. | Schreiber Taylor | CEO, Dir | M - OptEx | $4.67 | +3,926 | 13.1K | +43% | +$18.3K |
| D | 2021-08-11 | 2021-08-10 | STTK | Shattuck Labs, Inc. | Schreiber Taylor | CEO, Dir | M - OptEx | $4.67 | +3,926 | 9,200 | +74% | +$18.3K |
Purchase Sale Sale after option exercise All abbreviations